Correlation Between Taisho Pharmaceutical and Sunshine Biopharma

Can any of the company-specific risk be diversified away by investing in both Taisho Pharmaceutical and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taisho Pharmaceutical and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Taisho Pharmaceutical Holdings and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Taisho Pharmaceutical and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taisho Pharmaceutical with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taisho Pharmaceutical and Sunshine Biopharma.

Diversification Opportunities for Taisho Pharmaceutical and Sunshine Biopharma

0.01

Correlation Coefficient

Taisho Pharmaceutical  Sunshine Biopharma

Significant diversification

The 3 months correlation between Taisho and Sunshine is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Taisho Pharmaceutical Holdings and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Taisho Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taisho Pharmaceutical Holdings are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Taisho Pharmaceutical i.e., Taisho Pharmaceutical and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Taisho Pharmaceutical and Sunshine Biopharma

If you would invest  12.00  in Sunshine Biopharma Warrant on September 18, 2024 and sell it today you would earn a total of  10.00  from holding Sunshine Biopharma Warrant or generate 83.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	1.72%
Values	Daily Returns

Taisho Pharmaceutical Holdings  vs.  Sunshine Biopharma Warrant

Taisho Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Taisho Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Taisho Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sunshine Biopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Taisho Pharmaceutical and Sunshine Biopharma

The main advantage of trading using opposite Taisho Pharmaceutical and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taisho Pharmaceutical position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.

The idea behind Taisho Pharmaceutical Holdings and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.